Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs - ScienceDirect
Schematic representation of PAI-1 action. PAI-1 not only inhibits local... | Download Scientific Diagram
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
British Journal of Haematology | Wiley Online Library
PAI-1 Assays
A Role for Plasminogen Activator Inhibitor-1 in Obesity: From Pie to PAI? | Arteriosclerosis, Thrombosis, and Vascular Biology
LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy: Molecular Therapy
Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease
IJMS | Free Full-Text | Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis
Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance | Cell Death & Disease
IJMS | Free Full-Text | PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?
Possible interactions of PAI-1 with cell surface molecules and its... | Download Scientific Diagram
Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease. | Semantic Scholar
PAI-1: An Integrator of Cell Signaling and Migration
Anti-PAI-1 Monoclonal Antibody Inhibits the Metastasis and Growth of Esophageal Squamous Cell Carcinoma
PAI-1 and TGF-β | Arteriosclerosis, Thrombosis, and Vascular Biology
PDF] Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. | Semantic Scholar
gb HEMO PAI1 (4G/5G) - Generi Biotech
Frontiers | Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk